BIO Bio-Rad Laboratories Inc - Class A Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: BIO
  4. Earnings
?
Relative Growth: Rel. Growth: 22
Relative Strength: Rel. Strength: 80
Relative Valuation: Rel. Valuation: 24
Relative Profitability: Rel. Profitability: 41

EPS in 2026 (TTM): $8.05

Last Report Period Date: Jun 30, 2026

As of August this year, based on Bio-Rad Laboratories Inc - Class A's most recent financial report, the company's trailing twelve months EPS is $8.05. During 2025, BIO reported a per-share earnings of $27.87, which shows a rise compared to the EPS of -$65.36 recorded in 2024. Bio-Rad Laboratories Inc - Class A's EPS for the quarterly period ending on Jun 30, 2026 came in at $13.89.

BIO earnings history

Historical annual and quarterly earnings per share (EPS) data for Bio-Rad Laboratories Inc - Class A
EPS (TTM)
$8.05
EPS Growth YoY (Quarterly)
19%
EPS (Quarterly)
$13.89
EPS Growth (Quarterly)
171%

The yearly earnings per share during 2025 was $27.87, a rise of 142.6% compared to -$65.36 recorded in 2024. Over the quarter ending Jun 30, 2026, the earnings per share came in at $13.89, reflecting a 19% increase compared to the same quarter a year earlier. As of June 2026, the TTM EPS is $8.05. During 2024, the annual earnings per share was -$65.36, representing a decrease of 199.5% compared to 2023.

BIO EPS vs price chart

BIO EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
19%
EPS growth YoY
142.6%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
-26.3%

Bio-Rad Laboratories Inc - Class A has recorded a growth in earnings per share of 19% over the past 12 months (YoY, quarterly). Bio-Rad Laboratories Inc - Class A had an average annual EPS growth of -26.3% in the last five years. When assessed over a ten-year period, BIO's average EPS annual growth was 22.2%.

BIO Earnings Waterfall

Breakdown of revenue, profit and net income for Bio-Rad Laboratories Inc - Class A

BIO Earnings vs Peers

What are the earnings of BIO compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
JNJ Johnson & Johnson 30.96 90.6% 17.7% 14.8%
A Agilent Technologies Inc 31.8 3.4% 3.1% 14.5%
TMO Thermo Fisher Scientific Inc 33.8 7.2% 0% 2%
DHR Danaher Corp 38.73 -4.9% -19.7% 0.4%
GE General Electric Company 40.75 35.8% 447.4% 12.1%
BIO Bio-Rad Laboratories Inc - Class A 47.21 142.6% N/A -26.3%
BDX Becton Dickinson & Company 57.83 -0.9% -0.6% 16.2%
HBIO Harvard Bioscience Inc N/A -357.1% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.